Keeping Current

Keep up with the move toward targeted disease modifying therapies in Sjögren's disease.
Credit available for this activity expires: 05/12/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/addressing-unmet-needs-management-sj%C3%B6grens-disease-2026a1000dvs?ecd=bdc_podcast_libsyn_mscpedu

Recognize biliary atresia (BA) signs early to stop pediatric liver transplant. Gain expert insights on screening, diagnosis, and urgent referral pathways.
Credit available for this activity expires: 05/01/2027
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/challenges-and-opportunities-diagnostic-pathway-biliary-2026a1000bpb?ecd=bdc_podcast_libsyn_mscpedu

Improve real-world DME outcomes by mastering the interpretation of evolving biomarkers and the latest evidence on long-acting anti-VEGF therapies.
Credit available for this activity expires: [04/28/27]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/diabetic-macular-edema-express-q-whats-new-2026a1000czk?ecd=bdc_podcast_libsyn_mscpedu

Sodium-glucose cotransporter 2 (SGLT2) inhibitors transformed HF care. Meet SGLT1, a transporter that may unlock even greater CV protection.
Credit available for this activity expires: 4/10/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/science-sglt1-and-sglt2-unpacking-dual-inhibition-heart-2026a1000axj?ecd=bdc_podcast_libsyn_mscpedu

Intervening early can stop metabolic dysfunction-associated steatohepatitis (MASH) progressing to fibrosis. Which of your patients with type 2 diabetes (T2D) or obesity need treatment, and what therapies are available?
Credit available for this activity expires: 3/26/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/liver-fibrosis-type-2-diabetes-and-obesity-case-based-2026a10008y0?ecd=bdc_podcast_libsyn_mscpedu